View More 2024, Clinical Trials, Scientific Sessions, Session Coverage

Symposium on drugs used for diabetic retinopathy to include LENS results


Estimated Read Time:

1 minute

Researchers will highlight results from the LENS trial and the efficacy of fenofibrate in the treatment of diabetic retinopathy in a Friday, June 21, symposium.

David Preiss, MBChB, MRCP, FRCPath, PhD
David Preiss, MBChB, MRCP, FRCPath, PhD

Systemic Medications for Diabetic Retinopathy—Protective and Risk Factors will take place from 3:45 p.m. – 5:15 p.m. ET in Room W208 of the Orange County Convention Center. The session will be available on-demand on the virtual meeting platform for registered meeting participants following the 84th Scientific Sessions.

Fenofibrate has been used to lower cholesterol for more than three decades, and research suggests the drug may delay the progression of diabetic retinopathy, which is one of the main causes of blindness and poor vision among working-age adults.

More than 1,000 people with diabetes and retinopathy are participating in Lowering Events in Non-proliferative Retinopathy in Scotland (LENS), which is investigating the effects of fenofibrate on diabetic retinopathy progression.

David Preiss, MBChB, MRCP, FRCPath, PhD, University of Oxford, United Kingdom, will present LENS results.

The symposium also will include information on the role of systemic pharmacotherapy in the prevention and management of diabetic macular edema from Andrew J. Barkmeier, MD, Mayo Clinic.

Alicia Jenkins, MBBS, MD, FRACP, FRCP, Baker Heart and Diabetes Institute, will share data from the FAME 1 eye trial.

Satish K. Garg, MD, University of Colorado Denver, will discuss the effects of glucagon-like peptide 1 (GLP-1) receptor agonists on diabetic retinopathy.

Get On-Demand Access to the Scientific Sessions

There is still time to register for on-demand access to learn about the latest advances in diabetes research, prevention, and care presented at the 84th Scientific Sessions. Select session recordings will be available through Aug. 26.